Apratim Purakayastha

Much of the money and time in healthcare happens past the point of diagnosis. The money: $200B of spend on specialty drugs. The time: putting patients on therapies requires clinical judgment, and navigating a labyrinth of paperwork and people. The result is a byzantine status quo where patients get life saving therapies denied or delayed, and hospital systems capture only $80B of the $200B of drug spend that they originate. Latent’s groundbreaking clinical AI is a portal into the future. Patients get therapies quickly with personalized care, and hospitals transform their bottom line. As a result, Latent has seen extraordinary traction, working with over 50% of the top 20 U.S. health systems in under a year. Latent is one of the biggest and most strategic opportunities in healthcare, sitting in between providers, payors, patients, and pharma. Spark Capital is delighted to support Rishabh Jain and Sriram Somasundaram and this consequential company and to work with Sarah Guo and Michael Dixon.

72

Salesforce Ventures is proud to invest in Forterra, a company setting the operating standard for autonomy in the most complex, high-stakes environments. At a moment when defense technology is rapidly evolving, Forterra stands out as a pioneer - building systems that can automate vehicles and transform operations for entire fleets and missions, intelligently, flexibly, and without compromise. Our investment reflects a deep conviction: autonomous systems are not just the future of defense and logistics, but a critical capability for managing complexity in high-risk scenarios. Forterra's OASIS platform represents more than technology - it's an architectural approach that enables interoperability and intelligent mission execution. We're excited to partner with Josh Araujo, Scott Sanders, and the entire Forterra team, alongside an exceptional group of investors including Moore Capital Management, 9Yards Capital, Hedosophia, Franklin Templeton, and others who share our vision of transformative technology. https://lnkd.in/gnqkWMrN

101

4 Comments

I’m looking forward to speaking in Boston with a group of operators focused on a topic that matters more than ever: Revenue Activation. I’ll be sharing a core insight I’ve seen across high-performing teams — revenue activation isn’t about more enablement, more content, or more tools. It’s about activating sellers with the right guidance, in the right moment, against the reality of the deal in front of them. Most revenue teams don’t have a knowledge gap; they have an execution gap. Revenue activation is how leading organizations are closing it—without adding headcount or complexity. If you’re responsible for revenue outcomes and want a practical conversation grounded in what’s actually working, this will be a valuable room to be in. #RevenueActivation #GTMLeadership #AIinGTM #B2BSaaS #BostonEvent

53

There are few VCs who have the barbell experience of having analyzed both public tech companies & invested at the inception stage. It's like having a college professor who's also a kindergarten teacher. Our partner Elizabeth Harrow is such a unicorn. You can see why that's so useful in understanding what's going on today in her conversation with Clare O'Connor at Investor's Business Daily ... cc SHAKTI

14

1 Comment